-
Mezzion Reports Positive In Vivo Results for Udenafil in ADPKD
- August 2, 2026
- Posted by:
- Category: Business plans
No Comments
Seoul, Korea, Aug. 2, 2026 /PRNewswire/ — Mezzion Pharma Co., Ltd. today announced positive results from a new in vivo study of udenafil, a novel phosphodiesterase type 5 (PDE5) inhibitor, in autosomal dominant polycystic kidney disease (ADPKD). In…
-
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
- August 2, 2026
- Posted by:
- Category: Economics
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical Benefits Scheme (PBS) for adults with relapsed or refractory follicular lymphoma (R/R FL)…
-
Twitch Phenom Cinna Declares for Bang Energy During Record-Breaking Subathon Attempt
- August 1, 2026
- Posted by:
- Category: Finance & accounting
New Partnership Unveiled as Cinna Kicks Off Month-Long “Cinnathon” Livestream EventCORONA, Calif., Aug. 1, 2026 /PRNewswire/ — Bang Energy is marking one of its biggest plays yet in the creator economy with the announcement of its newest brand…